Skip to main
UNH

UnitedHealth Group (UNH) Stock Forecast & Price Target

UnitedHealth Group (UNH) Analyst Ratings

Based on 25 analyst ratings
Buy
Strong Buy 24%
Buy 56%
Hold 12%
Sell 8%
Strong Sell 0%

Bulls say

UnitedHealth Group is the largest health insurer in the U.S., with market leading positions in commercial risk and non-risk, Medicare Advantage and supplemental, and Medicaid. Its diverse offerings, strong cash flow generation, and Optum business segment provide a competitive advantage in the increasingly complex healthcare landscape. Near-term risks related to COVID-19 trends and legislative uncertainty are balanced by longer-term growth opportunities and strong financials.

Bears say

UnitedHealth Group is a leader in the medical insurance industry and has obtained massive scale through its insurance assets and Optum franchises. However, the company faces potential risks such as reimbursement reductions and increased competition in its Medicare Advantage business. While the recent earnings beat and raised guidance are positive indicators, the company's heavy reliance on first-half earnings and ongoing investments in AI may limit short-term profitability. Additionally, potential regulatory and legal risks could impact the company's operations.

UnitedHealth Group (UNH) has been analyzed by 25 analysts, with a consensus rating of Buy. 24% of analysts recommend a Strong Buy, 56% recommend Buy, 12% suggest Holding, 8% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of UnitedHealth Group and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About UnitedHealth Group (UNH) Forecast

Analysts have given UnitedHealth Group (UNH) a Buy based on their latest research and market trends.

According to 25 analysts, UnitedHealth Group (UNH) has a Buy consensus rating as of May 5, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $378.64, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $378.64, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

UnitedHealth Group (UNH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.